Beddok, A., Orlhac, F., Rozenblum, L., Calugaru, V., Créhange, G., Dercle, L., Nioche, C., Thariat, J., Marin, T., El Fakhri, G., & Buvat, I. (2024). Radiomics-driven personalized radiotherapy for primary and recurrent tumors: A general review with a focus on reirradiation. Cancer/Radiothérapie, 28(6–7), 597–602. https://doi.org/10.1016/j.canrad.2024.09.002

Fine, R. E., Gilmore, R. C., Tomkovich, K. R., Dietz, J. R., Berry, M. P., Hernandez, L. E., Columbus, K. S., Seedman, S. A., Fisher, C. S., Han, L. K., Manahan, E. R., Hicks, R. D., Vaidya, R. P., Curcio, L. D., Sevrukov, A. B., Kenler, A. S., Taback, B., Chen, M., Miller, M. E., … Boolbol, S. K. (2024). Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence. Annals of Surgical Oncology, 31(11), 7273–7283. https://doi.org/10.1245/s10434-024-16181-0

Diggs, A., Huang, Y., Melamed, A., Szamreta, E., Monberg, M. J., Hershman, D., & Wright, J. D. (2024). Patterns of use of primary and first-line chemotherapy for recurrence among patients with cervical cancer. International Journal of Gynecologic Cancer, 34(7), 1001–1010. https://doi.org/10.1136/ijgc-2023-004860

Ingram, J. W., Chung, R., Laplaca, C., McKiernan, J. M., Lenis, A. T., & Anderson, C. B. (2024). Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations, 42(9), 290.e11-290.e16. https://doi.org/10.1016/j.urolonc.2024.04.017

Van Tine, B. A., Ingham, M. A., Attia, S., Meyer, C. F., Baird, J. D., Brooks-Asplund, E., D’Silva, D., Kong, R., Mwatha, A., O’Keefe, K., Weetall, M., Spiegel, R., & Schwartz, G. K. (2024). Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of Clinical Oncology, 42(20), 2404–2414. https://doi.org/10.1200/jco.23.01684

Liu, M. A., Li, J. W., & Runcie, K. (2024). Management of Oligometastatic and Locally Recurrent Urothelial Carcinoma. Current Oncology Reports, 26(5), 496–503. https://doi.org/10.1007/s11912-024-01523-8

Maxwell, C. V., Shirley, R., O’Higgins, A. C., Rosser, M. L., O’Brien, P., Hod, M., O’Reilly, S. L., Medina, V. P., Smith, G. N., Hanson, M. A., Adam, S., Ma, R. C., Kapur, A., McIntyre, H. D., Jacobsson, B., Poon, L. C., Bergman, L., Regan, L., … Algurjia, E. (2023). Management of obesity across women’s life course: FIGO Best Practice Advice. International Journal of Gynecology & Obstetrics, 160(S1), 35–49. Portico. https://doi.org/10.1002/ijgo.14549

Lassman, A. B., Sepúlveda-Sánchez, J. M., Cloughesy, T. F., Gil-Gil, M. J., Puduvalli, V. K., Raizer, J. J., De Vos, F. Y. F., Wen, P. Y., Butowski, N. A., Clement, P. M. J., Groves, M. D., Belda-Iniesta, C., Giglio, P., Soifer, H. S., Rowsey, S., Xu, C., Avogadri, F., Wei, G., Moran, S., & Roth, P. (2022). Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clinical Cancer Research, 28(11), 2270–2277. https://doi.org/10.1158/1078-0432.ccr-21-2664

Lassman, A. B., Wen, P. Y., van den Bent, M. J., Plotkin, S. R., Walenkamp, A. M. E., Green, A. L., Li, K., Walker, C. J., Chang, H., Tamir, S., Henegar, L., Shen, Y., Alvarez, M. J., Califano, A., Landesman, Y., Kauffman, M. G., Shacham, S., & Mau-Sørensen, M. (2021). A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma. Clinical Cancer Research, 28(3), 452–460. https://doi.org/10.1158/1078-0432.ccr-21-2225

Ho, P., Moran, G. W., Wang, V., Li, G., Virk, R. K., McKiernan, J. M., & Anderson, C. B. (2022). The effect of tumor grade heterogeneity on recurrence in non-muscle invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations, 40(2), 60.e11-60.e16. https://doi.org/10.1016/j.urolonc.2021.07.003